دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Kidney health for all: preparedness for the unexpected in supporting the vulnerable
Li-Li Hsiao 1 , Kavya M. Shah 1 , Adrian Liew 2 , Dina Abdellatif 3 , Alessandro Balducci4 , A � gnes Haris 5 , Latha A. Kumaraswami 6 , Vassilios Liakopoulos 7 , Siu-Fai Lui 8,9 , Ifeoma Ulasi 10 and Robyn G. Langham 11 ; for the World Kidney Day Joint Steering Committee
doi : 10.1016/j.kint.2022.12.013
Volume 103, Issue 3, March 2023, Pages 436-443
Endemic rise in cases of acute kidney injury in children in Indonesia and Gambia: what is the likely culprit and why?
Tungki Pratama Umar 1 , Nityanand Jain 2 and Henri Azis
doi : 10.1016/j.kint.2022.12.004
Volume 103, Issue 3, March 2023, Pages 444-447
Soluble urokinase plasminogen activator receptor (suPAR) promotes atherosclerosis
Tilman B. Drueke 1 and Ziad A. Massy
doi : 10.1016/j.kint.2022.12.006
Volume 103, Issue 3, March 2023, Pages 451-454
That sinking gut feeling: is transplant-induced dysbiosis contributing to allograft outcomes?
Steven J. Chadban 1 , Julian Singer 1 and P. Toby Coates
doi : 10.1016/j.kint.2022.11.022
Volume 103, Issue 3, March 2023, Pages 454-457
Aquaporin-2 is not alone
Enno Klussmann
doi : 10.1016/j.kint.2022.11.014
Volume 103, Issue 3, March 2023, Pages 458-460
Protecting the kidney in sepsis: resident macrophages to the rescue
Kevin D. Burns 1,2 and Adrianna Douvris
doi : 10.1016/j.kint.2022.11.012
Volume 103, Issue 3, March 2023, Pages 461-463
Precision nephrology: from molecular diagnostics to an individualized therapy
Anne K. Mu ̈ hlig 1,2,3,4 , Jun Oh 1,3,4 and Tobias B. Huber
doi : 10.1016/j.kint.2022.12.017
Volume 103, Issue 3, March 2023, Pages 464-466
T-cell epitopes of PLA2R1 in membranous nephropathy: another step toward antigen-based immunotherapies
Elion Hoxha
doi : 10.1016/j.kint.2022.12.018
Volume 103, Issue 3, March 2023, Pages 466-469
Mapping antigens of membranous nephropathy: almost there
Sanjeev Sethi 1 and Benjamin Madden
doi : 10.1016/j.kint.2023.01.003
Volume 103, Issue 3, March 2023, Pages 469-472
Renal AA amyloidosis: presentation, diagnosis, and current therapeutic options: a review
Sabine Karam 1 , Mohamad Haidous 2 , Virginie Royal 3 and Nelson Leung
doi : 10.1016/j.kint.2022.10.028
Volume 103, Issue 3, March 2023, Pages 473-484
New advances in endocrine hypertension: from genes to biomarkers
Fabio L. Fernandes-Rosa 1,5 , Sheerazed Boulkroun 1,5 , Bakhta Fedlaoui 1 , Marguerite Hureaux 1,2 , Simon Travers-Allard 1,3 , Tom Drossart 1,4 , Judith Favier 1,4 and Maria-Christina Zennaro
doi : 10.1016/j.kint.2022.12.021
Volume 103, Issue 3, March 2023, Pages 485-500
Kidney tubular transcription co-activator, Yes-associated protein 1 (YAP), controls the expression of collecting duct aquaporins and water homeostasis
Yu Zhang 1 , Huihui Huang 2 , Yonglun Kong 1 , Chunhua Xu1 , Liujiang Dai1 , Xiaoqiang Geng 3 , Yujie Deng 4 , Yang Wang 1 , Yang Liu 1,5 , Chenling Meng 1 , Xiaoyi Zhang 1 , Jinhong Li 5 , Jinzhong Qin 6 , Bo Feng 1 , Kingston Kinglun Mak 7 , Li Wang 7 , Yu Huang 7 , Weidong Wang 8 , Hui-Yao Lan 9,10 , Baoxue Yang 3 , Hua A. Jenny Lu 2 and Yin Xia1,10,11
doi : 10.1016/j.kint.2022.10.007
Volume 103, Issue 3, March 2023, Pages 501-513
A macrophage-endothelial immunoregulatory axis ameliorates septic acute kidney injury
Jamie R. Privratsky 1,2 , Shintaro Ide 3 , Yanting Chen 1 , Hiroki Kitai 3 , Jiafa Ren 3 , Helene Fradin 4 , Xiaohan Lu 3 , Tomokazu Souma 3 and Steven D. Crowley 3,
doi : 10.1016/j.kint.2022.10.008
Volume 103, Issue 3, March 2023, Pages 514-528
Tubular-specific expression of HIV protein Vpr leads to severe tubulointerstitial damage accompanied by progressive fibrosis and cystic development
Yuqiang Chen 1,2,8 , Ya Chen 1,8 , Jia Fu 1,8 , Zeguo Sun 1,8 , Huilin Li 1 , Wenzhen Xiao 1 , Jing E 1 , Benjamin Y. Lo 1 , Niansong Wang 2 , Weijia Zhang 1 , Mary E. Klotman 3 , Paul E. Klotman 4 , Jeffrey B. Kopp 5 , Vivette D. D’Agati 6 , John Cijiang He 1,7 and Kyung Lee
doi : 10.1016/j.kint.2022.12.012
Volume 103, Issue 3, March 2023, Pages 529-543
Ubiquitin-specific protease 11 promotes partial epithelial-to-mesenchymal transition by deubiquitinating the epidermal growth factor receptor during kidney fibrosis
Yingfeng Shi1,4 , Min Tao 1,4 , Hui Chen 1,4 , Xiaoyan Ma 1 , Yi Wang 1 , Yan Hu 1 , Xun Zhou 1 , Jinqing Li 1 , Binbin Cui 1 , Andong Qiu 2 , Shougang Zhuang1,3 and Na Liu
doi : 10.1016/j.kint.2022.11.027
Volume 103, Issue 3, March 2023, Pages 544-564
Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis
Laura H. Mariani 1,45 , Sean Eddy1,45 , Fadhl M. AlAkwaa 1 , Phillip J. McCown 1 , Jennifer L. Harder 1 , Viji Nair 1 , Felix Eichinger1 , Sebastian Martini 1 , Adebowale D. Ademola 2 , Vincent Boima 3 , Heather N. Reich 4 , Jamal El Saghir 1 , Bradley Godfrey 1 , Wenjun Ju 1 , Emily C. Tanner 1 , Virginia Vega-Warner 1 , Noel L. Wys 1 , Sharon G. Adler5 , Gerald B. Appel 6
doi : 10.1016/j.kint.2022.10.023
Volume 103, Issue 3, March 2023, Pages 565-579
Mapping the T cell epitopes of the M-type transmembrane phospholipase A2 receptor in primary membranous nephropathy
Xiao-dan Zhang 1,2,3,4 , Cai-xia Lin 1,2,3,4 , Zhao Cui 1,2,3,4 , Qiu-hua Gu 1,2,3,4,5 , Bing-jia Yan 6 , Lei Liu 6,7 , Wen-chao Song 8,9 , Yi Shi 10 , Hanna Debiec 11,12 , Pierre Ronco 11,12,13,14 and Ming-hui Zhao
doi : 10.1016/j.kint.2022.11.021
Volume 103, Issue 3, March 2023, Pages 580-592
Discovery of seven novel putative antigens in membranous nephropathy and membranous lupus nephritis identified by mass spectrometry
Tiffany N. Caza 1 , Aaron J. Storey 2 , Samar I. Hassen 1 , Christian Herzog 2 , Rick D. Edmondson 2 , John M. Arthur 2 , Daniel J. Kenan 1 and Christopher P. Larsen
doi : 10.1016/j.kint.2023.01.001
Volume 103, Issue 3, March 2023, Pages 593-606
Individuals heterozygous for ALG8 protein-truncating variants are at increased risk of a mild cystic kidney disease
Benjamin Apple 1 , Gino Sartori 2 , Bryn Moore 3 , Kiran Chintam 4 , Gurmukteshwar Singh 4,5 , Prince Mohan Anand 6 , Natasha T. Strande 3,7 , Tooraj Mirshahi 3 , William Triffo 2 and Alexander R. Chang
doi : 10.1016/j.kint.2022.11.025
Volume 103, Issue 3, March 2023, Pages 607-615
Pathological characteristics of light chain crystalline podocytopathy
Samih H. Nasr 1,22 , Satoru Kudose 2,22 , Vincent Javaugue3,4,22 , Ste �phanie Harel 5 , Samar M. Said1 , Virginie Pascal 6 , M. Barry Stokes 2 , Julie A. Vrana 1 , Surendra Dasari 7 , Jason D. Theis 1 , George A. Osuchukwu 8 , Insara Jaffer Sathick 9,10 , Arjun Das11 , Ali Kashkouli 12 , Elliot J. Suchin 13 , Yaakov Liss 14 , Zalman Suldan 15 , Jerome Verine 16 , Bertrand Arnulf 5 , Alexis Talbot 5 , Sanjeev Sethi 1 , Mohamad Zaidan 17 , Jean-Michel Goujon18 , Anthony M. Valeri 19 , Ellen D. Mcphail 1 , Christophe Sirac 20 , Nelson Leung 3,21 , Frank Bridoux 4,20 and Vivette D. D’Agati
doi : 10.1016/j.kint.2022.11.026
Volume 103, Issue 3, March 2023, Pages 616-626
A Phase I/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipients
Aure �lie Moreau 1,14 , Delphine Kervella 1,2,14 , Laurence Bouchet-Delbos 1 , Ce �cile Braudeau 1,3 , Soraya Saı ̈agh 4 , Pierrick Gue �rif 2 , Sophie Limou 1 , Anne Moreau 5 , Sylvain Bercegeay 4 , Mathias Streitz 6,7 , Birgit Sawitzki 6 , Ben James 8 , Paul N. Harden9 , David Game 10 , Qizhi Tang11 , James F. Markmann 12 , Ian S.D. Roberts 13 , Edward K. Geissler 8 , Brigitte Dre �no4 , Re �gis Josien 1,3 , Maria-Cristina Cuturi 1,14, Gilles Blancho 1,2,14 ; and the DIVAT consortium
doi : 10.1016/j.kint.2022.08.037
Volume 103, Issue 3, March 2023, Pages 627-637
Individualize—but do not universally restrict—dietary potassium
Aarushi Varshney 1 , Leonie Dupuis 2 , Mario Mendoza-Sanchez 3 and Shivam Joshi
doi : 10.1016/j.kint.2022.12.007
Volume 103, Issue 3, March 2023, Page 638
The Author Replies
Rajiv Agarwal
doi : 10.1016/j.kint.2022.12.008
Volume 103, Issue 3, March 2023, Pages 638-639
Anti-PLA2R1 antibodies in membranous nephropathy: do we have the smoking gun?
Miguel Fribourg 1 and Paolo Cravedi
doi : 10.1016/j.kint.2022.10.031
Volume 103, Issue 3, March 2023, Page 639
The authors reply
Nicola M. Tomas 1 and Gunther Zahner
doi : 10.1016/j.kint.2022.12.014
Volume 103, Issue 3, March 2023, Pages 639-641
Perirenal IgG4-related disease
Wei Wang 1 , Chi-Ting Su2 , Wei-Chou Lin 3 , Chun-kai Huang 4 and Kao-Lang Liu
doi : 10.1016/j.kint.2022.10.011
Volume 103, Issue 3, March 2023, Page 642
Uremia-associated fibrinous pericarditis
Simona Pichler Sekulic 1 and Miroslav Sekulic
doi : 10.1016/j.kint.2022.10.014
Volume 103, Issue 3, March 2023, Page 643
The Case | A 48-year-old man with recurrent hypercalcemia and uremia after parathyroidectomy
Chien-Chou Chen 1,2 , I-Fang Yang 3 and Shih-Hua Lin
doi : 10.1016/j.kint.2022.10.006
Volume 103, Issue 3, March 2023, Pages 645-646
Subscription Information
doi : 10.1016/S0085-2538(23)00018-2
Volume 103, Issue 3, March 2023, Page A5
Table of Contents
doi : 10.1016/S0085-2538(23)00019-4
Volume 103, Issue 3, March 2023, Pages A7, A9, A11
